EARNEST Partners’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-28
| Closed | -$3.15K | – | 803 |
|
|
2023
Q3 | $3.15K | Hold |
28
| – | – | ﹤0.01% | 917 |
|
|
2023
Q2 | $2.64K | Hold |
28
| – | – | ﹤0.01% | 952 |
|
|
2023
Q1 | $2.83K | Hold |
28
| – | – | ﹤0.01% | 931 |
|
|
2022
Q4 | $3.34K | Hold |
28
| – | – | ﹤0.01% | 895 |
|
|
2022
Q3 | $3K | Hold |
28
| – | – | ﹤0.01% | 902 |
|
|
2022
Q2 | $3K | Hold |
28
| – | – | ﹤0.01% | 929 |
|
|
2022
Q1 | $3K | Hold |
28
| – | – | ﹤0.01% | 953 |
|
|
2021
Q4 | $2K | Hold |
28
| – | – | ﹤0.01% | 1036 |
|
|
2021
Q3 | $3K | Hold |
28
| – | – | ﹤0.01% | 967 |
|
|
2021
Q2 | $3K | Hold |
28
| – | – | ﹤0.01% | 980 |
|
|
2021
Q1 | $3K | Hold |
28
| – | – | ﹤0.01% | 971 |
|
|
2020
Q4 | $3K | Hold |
28
| – | – | ﹤0.01% | 951 |
|
|
2020
Q3 | $3K | Hold |
28
| – | – | ﹤0.01% | 904 |
|
|
2020
Q2 | $3K | Hold |
28
| – | – | ﹤0.01% | 878 |
|
|
2020
Q1 | $2K | Hold |
28
| – | – | ﹤0.01% | 902 |
|
|
2019
Q4 | $3K | Hold |
28
| – | – | ﹤0.01% | 939 |
|
|
2019
Q3 | $3K | Hold |
28
| – | – | ﹤0.01% | 909 |
|
|
2019
Q2 | $2K | Hold |
28
| – | – | ﹤0.01% | 1009 |
|
|
2019
Q1 | $2K | Hold |
28
| – | – | ﹤0.01% | 1017 |
|
|
2018
Q4 | $2K | Hold |
28
| – | – | ﹤0.01% | 981 |
|
|
2018
Q3 | $3K | Hold |
28
| – | – | ﹤0.01% | 946 |
|
|
2018
Q2 | $3K | Hold |
28
| – | – | ﹤0.01% | 946 |
|
|
2018
Q1 | $2K | Hold |
28
| – | – | ﹤0.01% | 1006 |
|
|
2017
Q4 | $2K | Buy |
+28
| New | +$2K | ﹤0.01% | 1004 |
|
|
2017
Q1 | – | Sell |
-28
| Closed | -$1K | – | 664 |
|
|
2016
Q4 | $1K | Buy |
+28
| New | +$1K | ﹤0.01% | 1050 |
|